Organ shortage: Ethics, law and pragmatism

Organ Shortage: Ethics, Law and Pragmatism

Volumn , Issue , 2011, Pages 1-327

  Farrell, Anne Maree ^a   Price, David ^b   Quigley, Muireann ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928423126     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511973536     Document Type: Book

References (488)

1. Abadie, A. and Gay, S., “The impact of presumed consent legislation on cadaveric organ donation: a cross-country study’, Journal of Health Economics, 25 (2006), 599–620.
2. Abecassis, M., Adams, M., Adams, P., Arnold, R., Atkins, C., Barr, M., Bennett, W., Bia, M., Briscoe, D., Burdick, J., Corry, R., Davis, J., Delmonico, F., Gaston, R., Harmon, W., Jacobs, C., Kahn, J., Leichtman, A., Miller, C., Moss, D., Newmann, J., Rosen, L., Siminoff, L., Spital, A., Starnes, V., Thomas, C., Tyler, L., Williams, L., Wright, F., Youngner, S., Live Organ Donation Consensus Group, “Consensus statement on the live organ donor’, Journal of the American Medical Association, 284 (2000), 2919–26.
3. Academy of Medical Royal Colleges, A Code of Practice for the Diagnosis and Confirmation of Death (London: Academy of Medical Royal Colleges, 2008).
4. Alexandre, G., Squifflet, J., De Bruyere, M., Latinne, D., Moriau, M., Carlier, M., Pirson, Y., Lecomte, C., “ABO-incompatible related and unrelated living donor renal allografts’, Transplantation Proceedings, 18 (1986), 452–5.
5. Alkhawari, F., Stimson, G. and Warrens, A., “Attitudes towards transplantation in UK Muslim Indo-Asians in West London’, American Journal of Transplantation, 5 (2005), 1326–31.
6. American Medical Association, “Consensus statement on the live organ donor’, Journal of the American Medical Association, 284 (2000), 2919–26.
7. Angoitia Gorostiaga, V., “El régimen reglamentario de la extracción y trasplante de órganos’ in Romeo-Casabona, C., El Nuevo Régimen Jurídico de Los Trasplantes de Órganos y Tejidos (Granada: Comares, 2005), 137–244.
8. ANZDATA, The 32nd Annual Report (2009), www.anzdata.org.au.
9. Arnold, R. and Youngner, S., “The dead donor rule: should we stretch it, bend it, or abandon it?’, Kennedy Institute of Ethics Journal, 3 (1993), 263–78.
10. Arnold, R., Bartlett, S., Bernat, J., Colonna, J., Dafoe, D., Dubler, N., Gruber, S., Kahn, J., Luskin, R., Nathan, H., Orloff, S., Prottas, J., Shapiro, R., Ricordi, C., Youngner, S., Delmonico, F., “Financial incentives for cadaveric organ donation: an ethical reappraisal’, Transplantation, 73 (2002), 1361–7.
11. Audard, V., Matignon, M., Dahan, K., Lang, P., Grimbert, P., “Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview’, Transplant International, 21 (2008), 11–17.
12. Bagheri, A., “Compensated kidney donation: an ethical review of the Iranian Model’, Kennedy Institute of Ethics Journal, 16 (2006), 269–82.
13. Baines, L., Joseph, J. and Jindal, R., “A public forum to promote organ donation amongst Asians: the Scottish initiative’, Transplant International, 15 (2002), 124–31.
14. Balpuri, S., Buckley, P., Snowdon, C., Mustafa, M., Sen, B., Griffiths, P., Hannon, M., Manas, D., Kirby, J., Talbot, D., “The trouble with kidneys derived from the non heart-beating donor: a single centre 10 year experience’, Transplantation, 69 (2000), 842–6.
15. Banner, N., Rose, M., Cummins, D., de Silva, M., Pottle, A., Lyster, H., Doyle, P., Carby, M., Khaghani, A., “Management of an ABO-incompatible lung transplant’, American Journal of Transplantation, 4 (2004), 1192–6.
16. Barber, K., Falvey, S., Hamilton, C., Collett, D., Rudge, C., “Potential for organ donation in the United Kingdom: audit of intensive care records’, British Medical Journal, 332 (2006), 1124–7.
17. Barlow, A., Metcalfe, M., Johari, Y., Elwell, R., Veitch, P., Nicholson, M., “Casematched comparison of long term results of non-heart beating and heartbeating donor renal transplants’, British Journal of Surgery, 96 (2009), 685–91.
18. Bartucci, M. and Seller, M., “Donor family responses to kidney recipient letters of thanks’, Transplantation Proceedings, 18 (1986), 401–4.
19. BBC News, “Racist organ donation condemned’ (24 February 2000), http://news.bbc.co.uk.1.hi.health.652132.stm.
20. BBC News, “GMC hears “organs for sale” case’ (22 September 2000), http://news.bbc.co.uk/1/hi/health/937204.stm.
21. BBC News, “Living organ donor drive launched’ (30 May 2005), http://news.bbc.co.uk/2/hi/health/4586565.
22. BC Transplant, “33 years and still counting’, Transplant Times (winter 2003), www.transplant.bc.ca/2003_times.htm.
23. Becker, E., The Denial of Death (London: The Free Press, 1973).
24. Becker, G. and Elías, J., “Introducing incentives in the market for live and cadaveric organ donations’, Journal of Economic Perspectives, 21 (2007), 3–24.
25. Bell, D., “Non-heart-beating organ donation: old procurement strategy – new ethical problems’, Journal of Medical Ethics, 29 (2003), 176–81.
26. Bellali, T. and Papadatou, D., “Parental grief following the brain death of a child: does consent or refusal to organ donation affect their grief?’, Death Studies, 30 (2006), 883–917.
27. Bellali, T. and Papadatou, D., “The decision-making process of parents regarding organ donation of their brain dead child: a Greek study’, Social Science & Medicine, 64 (2007), 439–450.
28. Ben-David, O., Organ Donation and Transplantation: Body Organs as an Exchangeable Socio-Cultural Resource (Westport: Praeger, 2005).
29. Berardinelli, L., Beretta, C., Raiteri, M., Carini, M., “Early and long term results using older kidneys from cadaver and living donors’, Clinical Transplantation, (2001), 157–66.
30. Bernat, J., “The whole-brain concept of death remains optimum public policy’, Journal of Law, Medicine and Ethics, 34 (2006), 35–43.
31. Bernat, J., Culver, C. and Gert, B., “On the definition and criterion of death’, Annals of Internal Medicine, 94 (1981), 389–94.
32. Bernat, J., Capron, A., Bleck, T., Blosser, S., Bratton, S., Childress, J., DeVita, M., Fulda, G., Gries, C., Mathur, M., Nakagawa, T., Rushton, C., Shemie, S., White, D., “The circulatory-respiratory determination of death in organ donation’, Critical Care Medicine, 38 (2010), 972–9.
33. Biotechnology and Biological Sciences Research Council, (BBSRC), Research Grants: The Guide (BBSRC Research Innovation and Skills Directorate, October 2009), www.bbsrc.ac.uk/funding/apply/grants_guide.pdf.
34. Boucek, M., Mashburn, C., Dunn, S., Frizell, R., Edwards, L., Pietra, B., Campbell, D., “Pediatric heart transplantation after declaration of cardiocirculatory death’, New England Journal of Medicine, 359 (2008), 709–14.
35. Boudville, N., Prasad, G., Knoll, G., Muirhead, N., Thiessen-Philbrook, H., Yang, R., Rosas-Arellano, M., Housawi, A., Garg, A., “Meta-analysis: risk for hypertension in living kidney donors’, Annals of Internal Medicine, 145 (2006), 185–96.
36. Bowlby, J., Attachment and Loss (Vol. 1: Attachment) (London: The Hogarth Press, 1969).
37. Bowlby, J., Attachment and Loss (Vol. 2: Separation) (London: The Hogarth Press, 1973).
38. Bowlby, J., Attachment and Loss (Vol. 3: Loss: Sadness and Depression) (London: The Hogarth Press, 1980).
39. Brazier, M., “Retained organs: ethics and humanity’, Legal Studies, 22 (2002), 550–69.
40. Brazier, M., “Do no harm – do patients have responsibilities too?’, Cambridge Law Journal, 65 (2006), 397–422.
41. Brazier, M., “Human(s) (as) medicine(s)’, in MacLean, S. (ed.), First Do No Harm (Aldershot: Ashgate, 2006), pp. 187–202.
42. Brazier, M., “Exploitation and enrichment: the paradox of medical experimentation’, Journal of Medical Ethics, 34 (2008), 180–5.
43. Brazier, M. and Quigley, M., “Deceased organ donation: in praise of pragmatism’, Clinical Ethics, 2 (2007), 164–5.
44. Brenner, B., Cooper, M., de Zeeuw, D., Keane, W., Mitch, W., Parving, H., Remuzzi, G., Snapinn, S., Zhang, Z., Shahinfar, S. (for the RENAAL Study Investigators), “Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy’, New England Journal of Medicine, 345 (2001), 861–9.
45. Bristol Inquiry, Learning from Bristol: the Report of the Public Inquiry into Children’s Heart Surgery at the Bristol Royal Infirmary 1984–1995 (Command Paper: CM 5207, 2001) (www.bristol-inquiry.org.uk).
46. British Transplantation Society, Guidelines Relating to Solid Organ Transplants from Non-heart Beating Donors, www.bts.org.uk/transplantation/standards-andguidelines.
47. Brown, the Rt Hon. Gordon (the former Prime Minister), “Organs can help us make a difference’, Daily Telegraph, 14 January 2008.
48. Browne, A., “The Institute of Medicine on non-heart-beating organ transplantation’, Cambridge Quarterly of Healthcare Ethics, 17 (2008), 75–86.
49. Buell, J., Beebe, T., Trofe, J., Gross, T., Alloway, R., Hanaway, M., Woodle, E., “Donor transmitted malignancies’, Annals of Transplantation, 9 (2004), 53–6.
50. Burden, A., McNally, P., Feehally, J., Walls, J., “Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom’, Diabetic Medicine, 9 (1992), 641–5.
51. Burroughs, T., Hong, B., Kappel, D. and Freedman, B., “The stability of family decisions to consent or refuse organ donation: would you do it again?’, Psychosomatic Medicine, 60 (1998), 156–62.
52. Callender, C., “The results of transplantation in blacks: just the tip of the iceberg’, Transplantation Proceedings, 21 (1989), 3407–10.
53. Canadian Organ Replacement Registry, E-Statistics Report on Transplant, Wait List and Donor Statistics (Canadian Institute for Health Information, 2008).
54. Canadian Organ Replacement Registry, Organ Donor Activity in Canada, 1999–2008 (Canadian Institute for Health Information, 2009).
55. Canadian Organ Replacement Registry, Treatment of End-Stage Organ Failure in Canada 1999–2008 – Report of the Canadian Organ Replacement Register 2010 (Canadian Institute for Health Information, 2010).
56. Chadwick, R., “The market for bodily parts: Kant and duties to oneself’, Journal of Applied Philosophy, 6 (1989), 129–39.
57. Childress, J., “Ethics and the allocation of organs for transplantation’, Kennedy Institute of Ethics Journal, 6 (1996), 397–401.
58. Childress, J., “The failure to give: reducing barriers to organ donation’, Kennedy Institute of Ethics Journal, 11 (2001), 1–16.
59. Childress, J., “Putting patients first in organ allocation’, Cambridge Quarterly of Healthcare Ethics, 10 (2001), 365–76.
60. Cinotti, G. and Zucchelli, P., “Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies’, Nephrology Dialysis Transplantation, 16 (2001), 961–6.
61. Clancy, M., “Translating the success of organ breakthrough collaboratives from the USA to the UK’, British Journal of Transplantation, 2 (2008), 3–7.
62. Clavien, P., Dutkowski, P. and Trotter, J., “Requiem for a champion? Living donor liver transplantation’, Journal of Hepatology, 51 (2009), 635–7.
63. Coggon, J., “Best interests, public interest, and the power of the medical profession’, Health Care Analysis, 16 (2008), 219–32.
64. Coggon, J., “Doing what’s best: organ donation and intensive care’ in Danbury, C., Newdick, C., Waldmann, C. and Lawson, A. (eds.), Law and Ethics in Intensive Care (Oxford University Press, 2010) pp. 213–31.
65. Coggon, J., Brazier, M., Murphy, P., Price, D., Quigley, M., “Best interests and potential organ donors’, British Medical Journal, 336 (2008), 1346–7.
66. Cohen, L., “Increasing the supply of transplant organs: the virtues of a futures market’, George Washington Law Review, 58 (1989), 1–51.
67. Cohen, L., “A futures market in cadaveric organs: would it work?’, Transplantation Proceedings, 1 (1993), 60–1.
68. Collini, A., De Bartolomeis, C., Ruggieri, G., Barni, R., Berini, M., Carmellini, M., “Long-term outcome of renal transplantation from marginal donors’, Transplantation Proceedings, 38 (2006), 3398–9.
69. Commission of the European Communities (CEC), Commission staff working document: accompanying document to the Communication from the Commission to the European Parliament and the Council: organ donation and transplantation: policy actions at EU level: Summary of the Impact Assessment (SEC (2007) 705 Brussels, 30 May 2007).
70. Commission of the European Communities (CEC), 1st National Expert Meeting on Organ Donation and Transplantation at Community Level: Summary Report (Brussels, 13 July 2007), http://ec.europa.eu/health/ph_threats/human_substance/events_organs.en.htm.
71. Commission of the European Communities (CEC), Proposal for a Directive of the European Parliament and of the Council on the application of patients’ rights in cross-border healthcare (COM (2008) 414 final, 2 July 2008).
72. Commission of the European Communities (CEC), Action Plan on Organ Donation and Transplantation (2009–2015): Strengthened Cooperation between Member States (COM (2008) 819/3, Brussels, 8 December 2008).
73. Commission of the European Communities (CEC), Commission staff working document accompanying the proposal for a Directive of the European Parliament and of the Council on standards of quality and safety of human organs intended for transplantation and of the Commission action plan on organ donation and transplantation (2009–2015): Strengthened cooperation between Member States: Impact Assessment (SEC (2008) 2956 Brussels, 8 December 2008).
74. Commission of the European Communities (CEC), Proposal for a Directive of the European Parliament and of the Council on standards of quality and safety of human organs intended for transplantation (COM (2008) 818 final, Brussels, 8 December 2008).
75. Commission of the European Communities (CEC), Experts Meeting on Organ Donation and Transplantation Action Plan 11–12 March 2009: Summary Report, http://ec.europa.eu/health/ph_threats/human_substance/oc_organs/docs/ev_20090311_mi_en.pdf.
76. Constitutional Law Committee (Finland), Statement Nr. 24 (2010).
77. Council of Europe, Meeting Organ Shortage: Current Status and Strategies for Improvement of Organ Donation. A European Consensus Document (1998), www.coe.int/t/dg3/health/Source/organshortage_en.doc.
78. Council of Europe, Transplant Newsletter: International Figures on Organ Donation and Transplantation –2004, 10(1) (2005).
79. Council of Europe, Transplant Newsletter: International Figures on Organ Donation and Transplantation –2007, 13(1) (2008).
80. Council of Europe, Transplant Newsletter: International Figures on Organ Donation and Transplantation –2008, 14(1) (2009).
81. Council of Europe, Transplant Newsletter: International Figures on Organ Donation and Transplantation –2009, 15(1) (2010).
82. Crespi, G., “Overcoming the legal obstacles to the creation of a futures market in bodily organs’, Ohio State Law Journal, 55 (1994), 1–77.
83. Cribb, A., Wainwright, S., Williams, C., Farsides, B., Michael, M., “Towards the applied: the construction of ethical positions in stem cell translational research’, Medicine, Health Care and Philosophy, 11 (2008), 351–61.
84. Crombie, A. and Franklin, P., “Family issues implicit in living donation’, Mortality, 11 (2006), 196–210.
85. Cronin, A. and Price, D., “Directed organ donation: is the donor the owner?’, Clinical Ethics, 3 (2008), 127–31.
86. Daar, A., “Rewarded gifting’, Transplantation Proceedings, 24 (1992), 2207–11.
87. Daniels, N. and Sabin, J., Setting Limits Fairly (Oxford University Press, 2002).
88. Danish Council of Ethics, Organ Donation – Ethical Deliberations and Recommendations (2008), Chapter 4.2.2, www.etikoglivet.dk/sw310.asp.
89. Darr, A. and Randhawa, G., “Public opinion and perception of organ donation and transplantation among Asian communities: an exploratory study in Luton, UK’, International Journal of Health Promotion and Education, 37 (1999), 68–74.
90. Davis, C. and Randhawa, G., “The influence of religion on organ donation among the Black Caribbean and Black African population – a pilot study in the UK’, Ethnicity & Disease, 16 (2006), 281–5.
91. Delmonico, F., “Exchanging kidneys – advances in living-donor transplantation’, New England Journal of Medicine, 350 (2004), 1812–14.
92. Delmonico, F., Arnold, R., Scheper-Hughes, N., Siminoff, L., Kahn, J., Youngner, S., “Ethical incentives – not payment – for organ donation’, New England Journal of Medicine, 346 (2002), 2002–5.
93. Den Hartogh, G., Farewell to Non-commitment: Decision Systems for Organ Donation from an Ethical Viewpoint (Monitoring Report Ethics and Health, 2008) (The Hague: Centre for Ethics and Health, 2008), www.ceg.nl.
94. Department of Health, An Investigation into Conditional Organ Donation (London: Department of Health, 2000).
95. Department of Health, The Report of the Bristol Royal Infirmary Inquiry (London: Department of Health, 2001).
96. Department of Health, National Service Framework for Diabetes: Standards (London: Department of Health, 2002).
97. Department of Health, The Isaacs Report: the Investigation of Events that Followed the Death of Cyril Mark Isaacs (London: Department of Health, 2003).
98. Department of Health, Saving Lives, Valuing Donors: a Transplant Framework for England (London: Department of Health, 2003).
99. Department of Health, National Service Framework for Renal Services (London: Department of Health, 2004).
100. Department of Health, Saving Lives, Valuing Donors – a Transplant Framework for England: One Year On (London: Department of Health, 2004).
101. Department of Health, 2006 Annual Report of the Chief Medical Officer: on the State of Public Health (London: Department of Health, 2007).
102. Department of Health, “Government announces appointment of new national clinical director for transplant’ (3 April 2008), http://nds/coi.gov.uk/Content/Detail.asp?ReleaseID=364434&NewsAreaID=2.
103. Department of Health, Legal Issues Relevant to Non-heart-beating Organ Donation (London: Department of Health, 2009), www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_109864.pdf.
104. Department of Health, Tackling Health Inequalities: 10 Years On (London: Department of Health, 2009).
105. Department of Health, Requested Allocation of a Deceased Donor Organ (March 2010), www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/dh/en/ps/documents/digitalasset/dh_114803.pdf.
106. Dew, M., Jacobs, C., Jowsey, S., Hanto, R., Miller, C., Delmonico, F., “Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States’, American Journal of Transplantation, 7 (2007), 1047–54.
107. Diabetes Prevention Program Research Group (DPPRG), “Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin’, New England Journal of Medicine, 346 (2002), 393–403.
108. Diario médico (Spain), 30 July 2009.
109. Dicksen, D., “Science and its public: the need for a “third way”’, Social Studies of Science, 30 (2000), 917–23.
110. Doward, J. and Campbell, D., “Transplant row over organs for drinkers’ (Observer, 15 February 2009).
111. DuBois, J., “Is organ procurement causing the death of patients?’, Issues in Law and Medicine, 18 (2002), 21–41.
112. Ducharme, H., “Thrift euthanasia in theory and practice’ in Freeman, M. and Lewis, A. (eds.), Law and Medicine: Current Legal Issues, Vol. 3 (Oxford University Press, 2000), pp. 493–525.
113. Duxbury, N., “Do markets degrade?’, Modern Law Review, 59 (1996), 331–53.
114. Editorial, “Liver transplantation from non-heart beating donors’, British Medical Journal, 332 (2006), 376–7.
115. Editorial, “Non-heart-beating organ donation – solution or a step too far?’, Anaesthesia, 62 (2007), 431–3.
116. Ellershaw, J. and Wilkinson, S., Care of the Dying: a Pathway to Excellence (Oxford University Press, 2003).
117. Elliot, J., “Brain death’, Trauma, 5 (2003), 23–42.
118. English, V. and Sommerville, A., “Presumed consent for transplantation: a dead issue after Alder Hey?’, Journal of Medical Ethics, 29 (2003), 147–52.
119. Ennis, J., Kocherginsky, M., Schumm, L., Worcester, E., Coe, F., Josephson, M., “Trends in kidney donation among kidney stone formers: a survey of US centres’, American Journal of Nephrology, 30 (2009), 12–18.
120. Epstein, R., “The human and economic dimensions of altruism: the case of organ transplantation’, Journal of Legal Studies, 37 (2008), 459–501.
121. Erin, C. and Harris, J., “A monopsonistic market – or how to buy and sell human organs, tissues and cells ethically’ in Robinson, I. (eds.), Life and Death under High Technology Medicine (Manchester University Press in association with the Fullbright Commission, London, 1994), pp. 134–53.
122. Erin, C. and Harris, J., “An ethical market in human organs’, Journal ofMedical Ethics, 29 (2003), 137–8.
123. Erin, C. and Harris, J., “Janet Radcliffe Richards on our modest proposal’, Journal of Medical Ethics, 29 (2003), 141–2.
124. Eurobarometer, Europeans and Organ Donation (Report: Special Eurobarometer 272D) (Brussels: European Commission, 2007), ec.europa.eu/public_opinion/archives/ebs/ebs_272d_en.pdf.
125. Europa, Press Release: Questions & Answers: EU Directive on Organ Donation and Transplantation (19 May 2010), http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/10/203&format=HTML&aged=0&language=EN& guiLanguage=en.
126. Evans, G. and Durant, J., “The relationship between knowledge and attitudes in the public understanding of science in Britain’, Public Understanding of Science, 4 (1995), 57–74.
127. Exley, C., Sim, J., Reid, N., Booth, L., Jackson, S., West, N., “Attitudes and beliefs within the Sikh community regarding organ donation: a pilot study’, Social Science and Medicine, 43 (1996), 23–8.
128. Exley, C., Sim, J., Reid, N., Booth, L., Jackson, S., West, N., “The admission of Asian patients to intensive therapy units and its implications for kidney donation: a preliminary report from Coventry, UK’, Journal of Epidemiology and Community Health, 50 (1996), 447–50.
129. Farrell, A., “Is the gift still good? Examining the politics and regulation of blood safety in the European Union’, Medical Law Review, 14 (2006), 155–79.
130. Farrell, A., Transplantation and the Organ Deficit in the UK: Pragmatic Solutions to Ethical Controversy – ESRC Seminar Series Final Report (2008), available at www.esrcsocietytoday.ac.uk.
131. Farrell, A., “The politics of risk and EU governance of human material’, Maastricht Journal of European and Comparative Law, 16 (2009), 41–64.
132. Farrell, A., “Adding value? EU governance of organ donation and transplantation’, European Journal of Health Law, 17 (2010), 51–79.
133. Farsides, B., Alderson, P. and Williams, C., “Aiming towards “moral equilibrium”: health care professionals’ views onworking within themorally contested field of antenatal screening’, Journal of Medical Ethics, 30 (2004), 505–9.
134. Featherstone, M., “The body in consumer culture’ in Featherstone, M., Hepworth, M. and Turner, B. (eds.), The Body: Social Process and Cultural Theory (London: Sage Publications, 1991), pp. 170–196.
135. Feest, T., Dunn, E. and Burton, C., “Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?’, QJM, 92 (1999), 275–82.
136. Fehrman-Ekholm, I., Duner, F., Brink, B., Tyden, G., Elinder, C., “No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up’, Transplantation, 72 (2001), 444–9.
137. Fehrman-Ekholm, I., Gabel, H. and Magnusson, G., “Reasons for not accepting living kidney donors’, Transplantation, 10 (1996), 695–9.
138. Feinberg, J., Harm to Others: the Moral Limits of the Criminal Law (New York: Oxford University Press, 1984).
139. Filipponi, F., De Simone, P. and Mosca, F., “Appraisal of the co-ordinator-based transplant organizational model’, Transplantation Proceedings, 37 (2005), 2421–2.
140. Filipponi, F., De Simone, P. and Rossi, E., “The Tuscany model of a regional transplantation service authority: Organizzazione Toscana Trapianti’, Transplantation Proceedings, 39 (2007), 2953–60.
141. Folkman, S., “Positive psychological states and coping with severe stress’, Social Science & Medicine, 45 (1997), 1207–21.
142. Foltyn, J., “Dead beauty: the preservation, memorialisation and destruction of beauty in death’, in Howarth, G. and Jupp, P. (eds.), Contemporary Issues in the Sociology of Death, Dying and Disposal (London: Macmillan, 1995), pp. 72–83.
143. Fortin, M., Roigt, D. and Doucet, H., “What should we do with patients who buy a kidney overseas?’, Journal of Clinical Ethics, 18 (2007), 23–4.
144. Foss, A., Heldal, K., Scott, H., Foss, S., Leivestad, T., Jorgensen, P., Scholz, T., Midtvedt, K., “Kidneys from deceased donors more than 75 years perform acceptably after transplantation’, Transplantation, 87 (2009), 1437–41.
145. Freud, S., Mourning and Melancholia (London: The Hogarth Press, 1917).
146. Frutos, M., “Percepción social de la donación’ in Matesanz, R. (ed.), El Modelo Español de Coordinación y Trasplantes, 2nd edn (Madria: Aula Médica Ediciones, 2008), pp. 161–73.
147. Frutos, M., Blanca, M., Ruiz, P., Mansilla, J., Seller, G., “Multifactorial snowball effect in the reduction of refusals for organ procurement’, Transplantation Proceedings, 37 (2005), 3646–8.
148. Frutos, M., Ruiz, P., Requena, M., Daga, D., “Family refusal in organ donation: analysis of three patterns’, Transplantation Proceedings, 34 (2002), 2513–14.
149. Gardiner, D. and Riley, B., “Non heart beating donation – solution or a step too far?’, Anaesthesia, 62 (2007), 431–3.
150. Garg, A., Muirehead, N., Knoll, G., Yang, R., Prasad, G., Thiessen-Philbrook, H., Rosas-Arellano, M., Housawi, A., Boudville, N., “Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis and meta-regression’, Kidney International, 70 (2006), 1801–10.
151. Garwood-Gowers, A., Living Donor Organ Transplantation: Key Legal and Ethical Issues (Aldershot: Ashgate, 1999).
152. Geddes, C., Rodger, R., Smith, C., Ganai, A., “Kidney transplants: more of them, better allocated’, British Medical Journal, 332 (2006), 1105–06.
153. GeneralMedical Council, Treatment and Care Towards the End of Life: Good Practice in Decision-Making (2010), www.gmc-uk.org/End_of_life.pdf_32486688.pdf.
154. German National Ethics Council Opinion, Increasing the Number of Organ Donations: a Pressing Issue for Transplant Medicine in Germany (Berlin: German National Ethics Council, 2007).
155. Gervais, K., Redefining Death (Yale University Press, 1986).
156. Gevers, S., “Editorial: a fair distribution of organs for transplantation purposes: looking to the past and the future’, European Journal of Health Law, 14 (2007), 215–19.
157. Ghobrial, R., Freise, C., Trotter, J., Tong, L., Ojo, A., Fair, J., Fisher, R., Emond, J., Koffron, A., Pruett, T., Olthoff, K., A2ALL Study Group, “Donor morbidity after living donation for liver transplantation’, Gastroenterology, 135 (2008), 468–76.
158. Giessing, M., Slowinski, T., Deger, S., Tuerk, I., Schonberger, S., Budde, K., Loening, S., “20 year experience with elderly donors in living renal transplants’, Transplant Proceedings, 35 (2003), 2855–7.
159. Giles, S., “An antidote to the emerging two tier organ donation policy in Canada: the Public Cadaveric Organ Donation Program’, Journal of Medical Ethics, 31 (2005), 188–91.
160. Gilks, W., Bradley, B., Gore, S., Klouda, P., “Substantial benefits of tissue matching in renal transplantation’, Transplantation, 43 (1987), 669–74.
161. Gilks, W., Gore, S. and Bradley, B., “Predicting match grade and waiting time to kidney transplantation’, Transplantation, 51 (1991), 618–24.
162. Gill, M. and Sade, R., “Paying for kidneys: the case against prohibition’, Kennedy Institute of Ethics Journal, 12 (2002), 17–45.
163. Gillon, R., “On giving preference to prior volunteers when allocating organs for transplantation’, Journal of Medical Ethics, 21 (1995), 199–204.
164. Gimbel, R., Strosberg, M., Lehrman, S., Gefenas, E., Taft, F., “Presumed consent and other predictors of cadaveric organ donation in Europe’, Progress in Transplantation, 13 (2003), 17–23.
165. Goldfarb, D., Martin, S., Braun, W., Schreiber, M., Mastroianni, B., Papajcik, D., Rolin, H., Flechner, S., Goormastic, M., Novick, A., “Renal outcome 25 years after donor nephrectomy’, Journal of Urology, 166 (2001), 2043–7.
166. Gómez, P. and De Santiago, C., “La entrevista familiar. Técnica y resultados’ in Matesanz, R. (ed.), El Modelo Español de Coordinación y Trasplantes, 2nd edn (Madrid: Aula Médica Ediciones, 2008), pp. 105–19.
167. Gómez, P., De Santiago, C., Getino, A., Moñino, A., Richart, M., Cabrero, J., “La entrevista familiar: enseñanza de las técnicas de comunicación’, Nefrología, vol. XXI, Supp. 4 (2001), 57–64.
168. Gore, S., Cable, D. and Holland, A., “Organ donation from intensive care units in England and Wales: two year confidential audit of deaths in intensive care’, British Medical Journal, 304 (1992), 349–55.
169. Gray, J., Isaiah Berlin (Princeton University Press, 1996).
170. Griffiths, J., Verble, M., Falvey, S., Bell, S., Logan, L., Morgan, K., Wellington, F., “Culture change initiatives in the procurement of organs in the United Kingdom’, Transplantation Proceedings, 41 (2009), 1459–62.
171. Gupta, A., Iveson, V., Varagunam, M., Bodger, S., Sinnott, P., Thuraisingham, R., “Pre-transplant donor specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?’, Transplantation, 85 (2008), 1081–2.
172. Gutmann, T. and Land, W., “Ethics in living donor organ transplantation’, http://trans.klinikum.uni-muenchen.de/ethics.htm.
173. Haddad, H., Isaac, D., Legare, J., Pflugfelder, P., Hendry, P., Chan, M., Cantin, B., Giannetti, N., Zieroth, S., White, M., Warnica, W., Doucette, K., Rao, V., Dipchand, A., Cantarovich, M., Kostuk, W., Cecere, R., Charbonneau, E., Ross, H., Poirier, N., “Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary’, Canadian Journal of Cardiology, 25 (2009), 197–205.
174. Hanfling, O., Life and Meaning: a Reader (Oxford: Basil Blackwell, 1987).
175. Harris, J., “The Marxist conception of violence’, Philosophy and Public Affairs, 3 (1974), 192–220.
176. Harris, J., “The survival lottery’, Philosophy, 50 (1975), 81–8.
177. Harris, J., The Value of Life (London: Routledge & Kegan Paul, 1985).
178. Harris, J., “Rights and reproductive choice’ in Harris, J. and Holm, S. (eds.), The Future of Human Reproduction: Choice and Regulation (Oxford University Press, 1998), pp. 5–37.
179. Harris, J., “Law and regulation of retained organs: the ethical issues’, Legal Studies, 22 (2002), 527–49.
180. Harris, J., “Organ procurement: dead interests, living needs: cadaver organs should be automatically available’, Journal of Medical Ethics, 29 (2003), 130–4.
181. Harris, J., On Cloning (London: Routledge, 2004).
182. Harris, J., “Scientific research is a moral duty’, Journal of Medical Ethics, 31 (2005), 242–8.
183. Harris, J., “Sex selection and regulated hatred’, Journal of Medical Ethics, 31 (2005), 291–5.
184. Harris, J. and Holm, S., “Should we presume moral turpitude in our children? Small children and consent to medical research’, Theoretical Medicine and Bioethics, 24 (2003), 121–9.
185. Harris, M., “The donor’s tale’, Journal of Medical Ethics, 34 (2008), 511–12.
186. Hayward, C. and Madill, A., “The meanings of organ donation: Muslims of Pakistani origin and white English nationals living in North England’, Social Science and Medicine, 57 (2003), 389–401.
187. Health Canada, Canada’s Healthcare System (Medicare), www.hc-sc.gc.ca/hcs-sss/medi-assur/index-eng.php.
188. Heller, R., GM Nation? The Findings of the Public Debate (London: Department of Trade and Industry, 2003).
189. Henderson, A., Landolt, M., McDonald, M., Barrable, W., Soos, J., Gourlay, W., Allison, C., Landsberg, D., “The living anonymous kidney donor: lunatic or saint?’, American Journal of Transplantation, 3 (2003), 203–13.
190. House of Lords, European Union Committee, Increasing the Supply of Donor Organs within the European Union, 17th Report of Session 2007–08, Volume 1: Report, HL Paper 123–I (London: The Stationery Office, 2008).
191. Hsu, C., McCulloch, C., Iribarren, C., Darbinian, J., Go, A., “Body mass index and risk for end-stage renal disease’, Annals of Internal Medicine, 144 (2006), 21–8.
192. Human Tissue Authority, Briefing Notes on the Human Tissue Act 2004 (30 August 2006).
193. Human Tissue Authority, Code of Practice: Donation of Organs, Tissue and Cells for Transplantation, Code 2 (2006).
194. Human Tissue Authority, Stakeholder Evaluation, General Public Qualitative & Quantitative Research (June 2007).
195. Human Tissue Authority, Written Evidence to the Select Committee on the European Union’s Inquiry into the EU Commission’s Communication on Organ Donation and Transplantation: Policy Options at EU Level (2007), www.hta.gov.uk.
196. Hume, D. and Merrill, J., “Experiences with renal homotransplantation in the human: report of nine cases’, Journal of Clinical Investigation, 34 (1955), 327–82.
197. Huxtable, R., “Whatever you want? Beyond the patient in medical law’, Health Care Analysis, 16 (2008), 288–301.
198. Iberoamerican Network/Council of Donation and Transplantation (RCIDT), Trasplante Iberoamérica Newsletter (2009), www.ont.es.
199. Institute for Healthcare Improvement, Improvement Report: Organ Donation Breakthrough Collaborative (2006), www.ihi.org.
200. Institute of Medicine, Non-Heart-Beating Organ Transplantation: Medical and Ethical Issues in Procurement (Washington, DC: National Academies Press, 1998).
201. Institute of Medicine, Non-Heart-Beating Organ Transplantation: Practice and Protocols (Washington, DC: National Academy Press, 2000).
202. Institute of Medicine, Organ Donation: Opportunities for Action (Washington, DC: National Academies Press, 2006).
203. Irwin, A., “Beyond the toolkit: bringing engagement into practice’ in Turney, J., Engaging Science: Thoughts, Deeds, Analysis and Action (London: Wellcome Trust, 2006), 50–5.
204. Iserson, K., Death to Dust: What Happens to Dead Bodies? (Tucson: Galen Press Ltd, 1994).
205. Jain, N., Farooqi, A. and Feehally, J., “Raising awareness of chronic kidney disease among South Asians and primary care: the ABLE project’, Journal of Renal Care, 34 (2008), 173–8.
206. Jarvis, R., “Join the club: a modest proposal to increase availability of donor organs’, Journal of Medical Ethics, 21 (1995), 199–204.
207. Jasper, J., Nickerson, C., Ubel, P., Asch, D., “Altruism, incentives, and organ donation: attitudes of the transplant community’, Medical Care, 42 (2004), 378–86.
208. Jeffrey, R., Woodrow, G., Mahler, J., Johnson, R., Newstead, C., “Indo-Asian experience of renal transplantation in Yorkshire: results of a 10 year survey’, Transplantation, 73 (2002), 1652–7.
209. Jimenez, M., “A surgical marathon that spanned the country: unprecedented chain of kidney transplants traded vitally needed organs among three recipients in three different cities all at once’, The Globe and Mail, Toronto, Canada, 25 June 2009.
210. Joffe, A., Anton, N. and deCaen, A., “Survey of pediatricians’ opinions on donation after cardiac death: are the donors dead?’, Pediatrics, 122 (2008), 967–74.
211. Johnson, E., Remucal, M., Gillingham, K., Dahms, R., Najarian, J., Matas, A., “Complications and risks of living donor nephrectomy’, Transplantation, 64 (1997), 1124–8.
212. Johnson, M., Owen, D. and Blackburn, C., Black and Minority Ethnic Groups in England: The Second Health and Lifestyles Survey (London: Health Education Authority, 2000).
213. Johnson, R., Allen, J., Fuggle, S., Bradley, J., Rudge, C., “Early experience of paired living kidney donation in the United Kingdom’, Transplantation, 86 (2008), 1672–7.
214. Jones, M., “Elective ventilation of potential organ donors: the legal background’, British Medical Journal, 310 (1995), 714–18.
215. Karpinski, M., Knoll, G., Cohn, A., Yang, R., Garg, A., Storsley, L., “The impact of accepting living kidney donors with mild hypertension or proteinuria on transplantation rates’, American Journal of Kidney Disease, 47 (2006), 317–23.
216. Kasiske, B., Ma, J., Louis, T., Swan, S., “Long-term effects of reduced renal mass in humans’, Kidney International, 48 (1995), 814–19.
217. Kauffmann, H., Cherikh, W., McBride, M., Cheng, Y., Hanto, D., “Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update’, Transplantation, 84 (2007), 272–4.
218. Kellehear, A., “Dying as a social relationship: a sociological review of debates on the determination of death’, Social Science & Medicine, 66 (2008), 1533–44.
219. Kennedy, I., Sells, R., Daar, A., Guttmann, R., Hoffenberg, R., Lock, M., Radcliffe-Richards, J., Tilney, N., “The case for “presumed consent” in organ donation’, Lancet, 351 (1998), 1650–2.
220. Kent, B., “Protection behaviour: a phenomenon affecting organ and tissue donation in the 21st century?’, International Journal of Nursing Studies, 41 (2004), 273–84.
221. Kesselring, A., Kainz, M. and Kiss, A., “Traumatic memories of relatives regarding brain death, request for organ donation and interactions with professionals in the ICU’, American Journal of Transplantation, 7 (2007), 211–17.
222. Khan, Z. and Randhawa, G., “Informing the UK’s South Asian communities on organ donation and transplantation’, European Dialysis and Transplant Nurses Journal, 25 (1999), 12–14.
223. Klass, D., Silverman, P. and Nickman, S., Continuing Bonds: New Understandings of Grief (Bristol: Taylor & Francis, 1996).
224. Klassen, A., Hall, A., Saksvig, B., Curbow, B., Klassne, D., “Relationship between patients’ perceptions of disadvantage and discrimination and listing for kidney transplantation’, American Journal of Public Health, 92 (2002), 811–17.
225. Koch, T., “Normative and prescriptive criteria: the efficacy of organ transplantation allocation protocols’, Theoretical Medicine, 17 (1996), 75–93.
226. Koenig, B., “Dead donors and the “shortage” of human organs: are we missing the point?’, American Journal of Bioethics, 3 (2003), 26–7.
227. Koffmann, G. and Gambaro, G., “Renal transplantation from non-heart-beating donors: a review of the European experience’, Journal of Nephrology, 16 (2003), 334–41.
228. Kokkinos, C., Antcliffe, D., Nanidis, T., Darzi, A., Tekkis, P., Papalois, V., “Outcome of kidney transplantation from non heart-beating versus heartbeating cadaveric donors’, Transplantation, 83 (2007), 1193–9.
229. Kondro, W., “Fragmented organ donation programs hinder progress’, Canadian Medical Association Journal, 175 (2006), 1043–5.
230. Kubler-Ross, E., On Death and Dying (New York: Macmillan, 1969).
231. Kuo, P., Lu, A. and Johnson, L., “Expanded criteria donors/high risk recipients is not always cheaper than haemodialysis’, Transplantation, 72 (2001), 554–5.
232. Kyriakides, G., Hadjigavriel, M., Hadjicostas, P., Nicolaides, A., Kyriakides, M., “Public awareness and attitudes toward transplantation in Cyprus’, Transplantation Proceedings, 25 (1993), 2279.
233. La Spina, F., Sedda, L., Pizzi, C., Verlato, R., Boselli, L., Candiani, A., Chiaranda, M., Frova, G., Gorgerino, F., Gravame, V., “Donor families’ attitudes toward organ donation: the North Italy transplant program’, Transplantation Proceedings, 25 (1993), 1699–1701.
234. Lamb, D., Death, Brain Death and Ethics (London: Croom Helm, 1985).
235. Landry, D., “Voluntary reciprocal altruism: a novel strategy to encourage deceased donation’, Kidney International, 69 (2006), 957–9.
236. Langley, G., Moen, R., Nolan, K., Nolan, T., Norman, C., Provost, L. (eds.), The Improvement Guide: A Practical Approach to Enhancing Organizational Performance (New York: Jossey-Bass, 1996).
237. Lavee, J., Ashkenazi, T. and Steinberg, D., “A new law for allocation of donor organs in Israel’, Lancet, 375 (2010), 1131–3.
238. Lazarus, R. and Folkman, S., Stress, Appraisal and Coping (New York: Springer-Verlag, 1984).
239. Lederer, S., Flesh and Blood: Organ Transplantation and Blood Transfusion in Twentieth-Century America (Oxford University Press, 2008).
240. Lee, C., Scandling, J., Shen, G., Salvatierra, O., Dafoe, D., Alfrey, E., “The kidneys that nobody wanted: support for the utilisation of expanded criteria donors’, Transplantation, 62 (1996), 1832–41.
241. Lee, R. and Morgan, D. (eds.), Death Rites: Law and Ethics at the End of Life (London: Routledge, 1996).
242. Lewis, E., Hunsicker, L., Clarke, W., Berl, T., Pohl, M., Lewis, J., Ritz, E., Atkins, R., Rohde, R., Raz, I. (for the Collaborative Study Group), “Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes’, New England Journal of Medicine, 345 (2001), 851–60.
243. Li, S., Chan, C. and Lee, D., “Helpfulness of nursing actions to suddenly bereaved family members in an accident and emergency setting in Hong Kong’, Journal of Advanced Nursing, 40 (2002), 170–80.
244. Lightstone, L., Preventing Kidney Disease: The Ethnic Challenge (Peterborough: National Kidney Research Fund, 2001).
245. Lindsay, B., “Translation of the Spanish model to Australia: pros and cons’, Nefrología, vol. XXI, Supp. 4 (2001), 130–3.
246. Lo, C., Fan, S., Liu, C., Yong, B., Wong, Y., Ng, I., Wong, J., “Safety and outcome of hepatitis B core antibody-positive donors in right-lobe living donor liver transplantation’, Liver Transplantation, 9 (2003), 827–32.
247. Long, T. and Sque, M., “An update on initiatives to increase organ donation: a UK perspective’, British Journal of Transplantation, 2 (2007), 10–15.
248. Long, T., Sque, M. and Addington-Hall, J., “Conflict rationalisation: how family members cope with a diagnosis of brain stem death’, Social Science & Medicine, 67 (2008), 253–61.
249. Long, T., Sque, M. and Addington-Hall, J., “What does the diagnosis of brain death mean to families approached about organ donation: a review of the literature’, Progress in Transplantation, 18 (2008), 118–25.
250. Long, T., Sque, M. and Payne, S., “Information sharing: its impact on donor and nondonor families’ experience in the hospital’, Progress in Transplantation, 16 (2006), 144–9.
251. Machado, C., “A definition of human death should not be related to organ transplants’, Journal of Medical Ethics, 29 (2003), 201–2.
252. Machado, C. and Shewmon, D. (eds.), Brain Death and Disorders of Consciousness (New York: Kluwer Academic, 2004).
253. Maloney, G. and Walker, I., “Talking about transplants: social representations and the dialectical, dilemmatic nature of organ donation and transplantation’, British Journal of Social Psychology, 41 (2002), 299–320.
254. Manyalich, M., Paredes, D. and Vilardell, J., “La donación de vivo para trasplantes’ in Matesanz, R. (ed.), El Modelo Español de Coordinación y Trasplantes, 2nd edn (Madrid: Aula Médica Ediciones, 2008), 181–5.
255. Marco Molina, J., “El régimen jurídico de la extracción y trasplante de órganos’, Diario la Ley, 5 (2001), 1714–20.
256. Martin, S., “Letter’, Canadian Medical Association Journal, 176 (2007), 1128.
257. Martínez, J., López, J., Martín, A., Martín, M., Martín, J., “Organ donation and family decision-making within the Spanish donation system’, Social Science& Medicine, 53 (2001), 405–21.
258. Marx, K. Critique of the Gotha Program (Rockville: Wildside Press, 2008).
259. Mason, J. and Laurie, G., Law and Medical Ethics, 7th edn (Oxford University Press, 2005).
260. Matas, A., “Design of a regulated system of compensation for living kidney donors’, Clinical Transplant, 22 (2008), 378–84.
261. Matesanz, R., “La insólita traslación del “modelo español” de donación de órganos al Reino Unido’, Nefrología, 21 (2001), 99–103.
262. Matesanz, R., “Factors influencing the adaptation of the Spanish Model of organ donation’, Transplant International, 16 (2003), 736–41.
263. Matesanz, R., “El modelo español de donación y trasplante de órganos: la ONT’ in Matesanz, R. (ed.), El Modelo Español de Coordinación y Trasplantes, 2nd edn (Madrid: Aula Médica Ediciones, 2008), pp. 11–26.
264. Matesanz, R., “El diagnóstico de la muerte encefálica en Latinoamérica’, Medicina Intensiva, 33 (2009), 423–4.
265. Matesanz, R. and Domínguez-Gil, B., “Strategies to optimize deceased organ donation’, Transplantation Reviews, 21 (2007), 177–88.
266. Matesanz, R., Domínguez-Gil, B., Martín Escobar, E., Mahillo, B., Carmona, M., Luengo, A., Álvarez, M., “La traslación del modelo español a otros países. Cooperación internacional’ in El Modelo Español de Coordinación y Trasplantes (Madrid: Aula Médica Ediciones, 2008), 271–308.
267. Matesanz, R. and Miranda, B., “Organ donation – the role of the media and of public opinion’, Nephrology Dialysis Transplantation, 11 (1996), 2127–8.
268. Matesanz, R. and Miranda, B., “A decade of continuous improvement in cadaveric organ donation: the Spanish model’, Journal of Nephrology, 15 (2002), 22–8.
269. Mauss, M., The Gift: The Form and Reason for Exchange in Archaic Societies (London: Routledge, 1990).
270. McAlister, V. and Badovinac, K., “Transplantation inCanada: report of theCanadian Organ Replacement Register’, Transplantation Proceedings, 35 (2003), 2428–30.
271. McDermott, M., “Obtaining consent for autopsy’, British Medical Journal, 327 (2003), 804–6.
272. McGuinness, S. and Brazier, M., “Respecting the living means respecting the dead too’, Oxford Journal of Legal Studies, 28 (2008), 297–316.
273. McHale, J., “Effective ventilation – pragmatic solution or ethical minefield’, Professional Negligence, 11 (1995), 23–7.
274. McLachlan, H., “Presumed consent is no consent at all’, www.bmj.com/cgi/eltters/336/7638/230#189028.
275. McMahan, J., The Ethics of Killing – Problems at the Margins of Life (Oxford University Press, 2002).
276. Medical Research Council, Applicant Handbook 2008–2009, www.mrc.ac.uk/Utilities/Documentrecord/index/htm.
277. Menikoff, J., “Doubts about death: the silence of the Institute of Medicine’, Journal of Law, Medicine and Ethics, 26 (1998), 157–65.
278. Menikoff, J., “The importance of being dead: non-heart-beating organ donation’, Issues in Law and Medicine, 18 (2002), 3–20.
279. Metzger, R., Delmonico, F., Feng, S., Port, F., Wynn, J., Merion, R., “Expanded criteria donors for kidney transplantation’, American Journal of Transplantation, 3 (Supp. 4) (2003), 114–25.
280. Mill, J., On Liberty (London: Penguin Books, 1985).
281. Ministry of Health and Consumer Affairs (Spain), Press Release: Symposium: Trasplante renal de donante vivo: nuevos retos, 23 June 2008.
282. Miranda, B., Cañón, J. and Cuende, N., “The Spanish organizational structure for organ donation – up to date’, Chirurgische Gastroenterologie, 18, 7–16.
283. Mittler, J., Pascher, A., Neuhaus, P., Pratschke, J., “The utility of extended criteria donor organs in severely ill liver transplant recipients’, Transplantation, 86 (2008), 895–6.
284. Mizraji, R., Alvarez, I., Palacios, R., Fajardo, C., Berrios, C., Morales, F., Luna, E., Milanés, C., Andrade, M., Duque, E., Giron, F., Alfonso J., Herra, S., Soratti, C., Ibar, R., Garcia, V., for the Punta Cana Group of Latin American Transplant Coordinators, “Organ Donation in Latin America’, Transplantation Proceedings, 39 (2007), 333–5.
285. Mizraji, R., Pérez, S. and Alvarez, I., “Activity of transplant coordination in Uruguay’, Transplantation Proceedings, 39 (2007), 339–40.
286. Moers, C., Leuvenink, H. and Ploeg, R., “Non-heart-beating organ donation: overview and future perspectives’, Transplant International, 20 (2007), 567–75.
287. Mollaret, P. and Goulon, M., “Le coma depasse’, Revue Neurologique, 101 (1959), 3–15.
288. Mongoven, A., “Sharing our body and blood: organ donation and feminist critiques of sacrifice’, Journal of Medicine and Philosophy, 28 (2003), 89–114.
289. Montgomery, R., Zachary, A., Ratner, L., Segev, D., Hiller, J., Cooper, M., Kavoussi, L., Jarrett, T., Burdick, J., Maley, W., Melancon, J., Kozlowski, T., Simpkins, C., Phillips, M., Desai, A., Collins, V., Reeb, B., Kraus, E., Rabb, H., Leffell, M., Warren, D., “Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation’, Journal of the AmericanMedical Association, 294 (2005), 1691–3.
290. Morgan, M., Hooper, R., Mayblin, M., Jones, R., “Attitudes to kidney donation and registering as a donor among ethnic groups in the UK’, Journal of Public Health, 28 (2006), 226–34.
291. Mullen, M., Kohut, N., Sam, M., Blendis, L., Singer, P., “Access to adult liver transplantation in Canada: a survey and ethical analysis’, Canadian Medical Assocation Journal, 154 (1996), 337–42.
292. Munoz, S., “Use of hepatitis B core antibody-positive donors for liver transplantation’, Liver Transplantation, 8 (2002), S82–7.
293. Murphy, P., Manara, A., Bell, D., Smith, M., “Controlled non-heart beating organ donation: neither the whole solution nor a step too far’, Anaesthesia, 63 (2008), 526–30.
294. Murray, J., Merrill, J., Dammin, G., Dealy, J., Walter, C., Brooke, M., Wilson, R., “Study on transplantation immunity after total body irradiation, clinical and experimental investigation’, Surgery, 48 (1960), 272–84.
295. Najarian, J., Chavers, B., McHugh, L., Matas, A., “Twenty years or more of follow-up of living kidney donors’, Lancet, 340 (1992), 807–10.
296. Narkun-Burgess, D., Nolan, C., Norman, J., Page, W., Miller, P., Meyer, T., “Forty-five year follow-up after uninephrectomy’, Kidney International, 43 (1993), 1110–15.
297. Nathan, H., Conrad, S., Held, P., McCullough, K., Pietroski, R., Siminoff, L., Ojo, A., “Organ donation in the United States’, 3 (2003), American Journal of Transplantation, 29–40.
298. National Assembly for Wales, Inquiry into Presumed Consent for Organ Donation (Health, Wellbeing and Local Government Committee, July 2008), www.assemblywales.org/cr-ld7192-e.pdf.
299. National Healthcare Service (Spain), Circular 3/1997, issued by the Dirección General de Atención Primariay Especializada, 10 April 1997.
300. Navarro-Michel, M., “Los derechos a la intimidad y propia imagen del menor de edad. Algunos supuestos conflictivos’, Revista de Derecho Privado, 2 (2009), 47–74.
301. Nazroo, J., The Health of Britain’s Ethnic Minorities (London: Policy Studies Institute, 1997).
302. Neades, B., “Healthcare professionals’ experiences in applying presumed consent legislation in organ donation in three European countries: a phenomenological study’ in Weimar, W., Bos, M. and Busschbach, J., Organ Transplantation: Ethical, Legal and Psychosocial Aspects (Lengerich: Pabst Science Publishers, 2008), pp. 150–4.
303. Neipp, M., Jackobs, S., Jaeger, M., Schwarz, A., Lueck, R., Gwinner, W., Becker, T., Klempnauer, J., “Living kidney donors >60 years of age: is it acceptable for the donor and the recipient?’, Transplant International, 19 (2006), 213–7.
304. NHS Blood and Transplant, Give and Let Live, www.giveandletlive.co.uk/en.
305. NHS Blood and Transplant, Transplant Activity in the UK 2006–2007 (2007), available at www.organdonation.nhs.uk.
306. NHS Blood and Transplant, Transplant Activity in the UK 2008–2009 (2009), available at www.organdonation.nhs.uk.
307. Nowenstein, G., “Organ procurement rates: does presumed consent legislation really make a difference?’, Law, Social Justice&Global Development Journal, 1 (2004), 1–17.
308. Ojo, A., “Expanded criteria donors: process and outcomes’, Seminars in Dialysis, 18 (2005), 463–8.
309. Ojo, A., Luan, F., Sung, R., Merion, R., “The use of expanded criteria donor organs for transplantation’, Transplantation Reviews, 20 (2006), 41–8.
310. Organ Donation Taskforce, Organs for Transplants: a Report from the Organ Donation Taskforce (London: Department of Health, 2008).
311. Organ Donation Taskforce, Organs for Transplants – The Supplement Report (London: Department of Health, 2008).
312. Organ Donation Taskforce, The Potential Impact of an Opt Out System for Organ Donation in the UK: an Independent Report from the Organ Donation Taskforce (London: Department of Health, 2008), www.dh.gov.uk/en/Publicationsandstatistics.Publications/PublicationsPolicyAndGuidance.DH_090312.
313. Organ Donation Taskforce, Working Together to Save Lives – The Organ Donation Taskforce Implementation Programme Annual Report 2008/9 (London: Department of Health, 2009).
314. Organización Nacional de Trasplantes (ONT), Consensus Document on Organ Retrieval after Cardiac Arrest (1995).
315. Organización Nacional de Trasplantes (ONT), Organ Shortage for Transplantation: Increasing Deceased Donation Activity Through the Spanish Model of Organization (18 June 2007), www.ont.es.
316. Organización Nacional de Trasplantes (ONT), Memoria de Actividad de Donación (2008), www.ont.es.
317. Organización Nacional de Trasplantes (ONT), Evolución de la Actividad de Donación y Trasplante en España (2010), www.ont.es.
318. Organizzazione Toscana Trapianti (OTT), Attività 2008, www.sanita.toscana.it.
319. Panorama (BBC), “Transplants: are donors really dead?’, BBC2, 13 October 1980.
320. Parker, F., Winslade, W. and Paine, C., “Organ procurement and tax policy’, Houston Journal of Health Law & Policy, 2 (2002), 173–85.
321. Pascual, J., Zamora, J. and Pirsch, J., “A systematic review of kidney transplantation from expanded criteria donors’, American Journal of Kidney Disease, 52 (2008), 553–8.
322. Payne, S., “Contemporary views of bereavement and the experience of grief’ in Sque, M. and Payne, S. (eds.), Organ and Tissue Donation: an Evidence Base for Practice (Maidenhead: Open University Press, 2007), 21–39.
323. Plamenatz, J., Consent, Freedom and Political Obligation, 2nd edn, (Oxford University Press, 1968).
324. Potts, M. and Evans, D., “Does it matter that organ donors are not dead? Ethical and policy implications’, Journal of Medical Ethics, 31 (2005), 406–9.
325. Potts, M. and Evans, D., “Is solid organ donation by living donors ethical? The case of kidney donation’ in Weimar, W., Bos, M. andBusschbach, J. (eds.), OrganTransplantation: Ethical, Legal and Psychosocial Aspects (Lengerich: Pabst Publishing, 2008), pp. 377–8.
326. Powers, M. and Faden, R., “Inequalities in health, inequalities in health care: four generations of discussion about justice and cost-effectiveness analysis’, Kennedy Institute of Ethics Journal, 10 (2000), 109–27.
327. President’s Council on Bioethics, Controversies in the Determination of Death (Washington, DC, 2008), www.bioethics.gov.
328. Pretagostini, R., De Simona, P., Peritote, D., Cortesini, R., “The organizational model of interregional transplant agency – Organizzazione Centro-Sud Trapianti’, Transplantation Proceedings, 37 (2005), 2417–8.
329. Price, D., Legal and Ethical Aspects of Organ Transplantation (Cambridge University Press, 2000).
330. Price, D., “The Human Tissue Act 2004’, Modern Law Review, 68 (2005), 798–821.
331. Price, D., Human Tissue in Transplantation and Research: a Model Legal and Ethical Donation Framework (Cambridge University Press, 2009).
332. Prottas, J., “Encouraging altruism: public attitudes and the marketing of organ donation’, Milbank Quarterly, 61 (1983), 278–306.
333. Punnett, A., McCarthy, L., Dirks, P., Hawkins, C., Bouffet, E., “Patients with primary brain tumours as organ donors: case report and review of the literature’, Paediatric Blood Cancer, 43 (2004), 73–7.
334. Quigley, M., “Directed deceased organ donation: the problem with algorithmic ethics’, www.ccels.cf.ac.uk/archives/issues/2008/quigley.pdf (2008).
335. Quigley, M., Brazier, M., Chadwick, R., Navarro-Michel, M., Paredes, D., “The organs crisis and the Spanish model: theoretical versus pragmatic considerations’, Journal of Medical Ethics, 34 (2008), 223–4.
336. Radcliffe-Richards, J., Daar, A., Guttmann, R., Kennedy, I., Lock, M., Sells, R., Tilney, N., “The case for allowing kidney sales’, Lancet, 351 (1998), 1950–2.
337. Radin, M., “Market-inalienability’, Harvard Law Review, 100 (1987), 1849–937.
338. Raleigh, V., “Diabetes and hypertension in Britain’s ethnic minorities: implications for the future of renal services’, British Medical Journal, 314 (1997), 209–12.
339. Randhawa, G., “Enhancing the health professional’s role in requesting transplant organs’, British Journal of Nursing, 6 (1997), 429–34.
340. Randhawa, G., “An exploratory study examining the influence of religion on attitudes towards organ donation among the Asian population in Luton, UK’, Nephrology Dialysis Transplantation, 13 (1998), 1949–54.
341. Randhawa, G., “The impending kidney transplant crisis for the Asian population in the UK’, Public Health, 112 (1998), 265–8.
342. Randhawa, G., “Increasing the donor supply from the UK’s Asian population: the need for further research’, Transplantation Proceedings, 32 (2000), 1561–2.
343. Randhawa, G., “Developing culturally competent renal services in the United Kingdom: tackling inequalities in health’, Transplantation Proceedings, 35 (2003), 21–3.
344. Randhawa, G., Jetha, C., Gill, B., Paramasivan, S., Lightstone, E., Waqar, M., “Understanding kidney disease and perceptions of kidney services among South Asians in West London: focus group study’, British Journal of Renal Medicine, 15 (2010), 23–7.
345. Rapaport, F., “Progress in organ procurement: the non-heart-beating cadaver donor and other issues in transplantation’, Transplantation Proceedings, 23 (1991), 2699–701.
346. Raphael, B., The Anatomy of Bereavement (London: Routledge, 1985).
347. Redfern, M., The Royal Liverpool Children’s Inquiry Report (London: The Stationery Office, 2001).
348. Reisaeter, A., “Kidney transplantation in Norway – an historical perspective’, Tidskrift for den Norske lægeforening, 119 (1999), 3163–6.
349. Rela, M. and Jassem, W., “Transplantation from non-heart-beating donors’, Transplantation Proceedings, 39 (2007), 726–7.
350. Rela, M. and Jassem, W., “Report of a National Conference on Donation after Cardiac Death’, American Journal of Transplantation, 6 (2006), 281–91.
351. Resende, L., Guerra, J., Santana, A., Mil-Homens, C., Abreu, F., da Costa, A., “Impact of donor age on renal allograft function and survival’, Transplantation Proceedings, 41 (2009), 794–6.
352. Review by a Working Group convened by the Royal College of Physicians and endorsed by the Conference of Medical Royal Colleges and their Faculties, “Criteria for the diagnosis of brain stem death’, Journal of the Royal College of Physicians of London, 29 (1995), 381–2.
353. Richardson, R., Death, Dissection and the Destitute, 2nd edn (University of Chicago Press, 2000).
354. Richardson, R., “Human dissection and organ transplantation in historical context’ in Sque, M. and Payne, S. (eds.), Organ and Tissue Donation: an Evidence Base for Practice (Maidenhead: Open University Press, 2007), pp. 4–20.
355. Ridley, S., Bonner, S., Bray, K., Falvey, S., Mackay, J., Manara, A., “Intensive Care Society’s Working Group on Organ and Tissue Donation, UKguidance for non-heart-beating donation’, British Journal of Anaesthesia, 95 (2005), 592–5.
356. Río-Gallegos, F., Escalante-Cobo, J., Núñez-Peña, J., Calvo-Manuel, E., “Donación tras la muerte encefálica. Parada cardíaca en el mantenimiento del donante en muerte encefálica’, Medicina Intensiva, 33 (2009), 327–35.
357. Rithalia, A., McDaid, C., Suekarran, S., Myers, L., Sowden, A., “Impact of presumed consent for organ donation on donation rates: a systematic review’, British Medical Journal, 338 (2009), a3162–70.
358. Robertson, J., “The dead donor rule’, Hastings Center Report, 29 (1999), 6–14.
359. Roderick, P., Raleigh, V., Hallam, L., Mallick, N., “The need and demand for renal replacement therapy amongst ethnic minorities in England’, Journal of Epidemiology and Community Health, 50 (1996), 334–9.
360. Rodríguez Lainz, J., “Juzgado de guardia y trasplante de órganos’, Diario La Ley, 6809 (2007), 1–20.
361. Romeo-Casabona, C., “Los principios jurídicos aplicables a los trasplantes de órganos y tejidos’ in Romeo-Casabona, C. (ed.), El Nuevo Régimen Jurídico de Los Trasplantes de Órganos y Tejidos (Granada: Comares, 2005), pp. 1–81.
362. Roscam Abbing, H., “A Council of Europe Protocol on Transplantation of Organs andTissue ofHuman Origin’, European Journal of Health Law, 9 (2002), 63–76.
363. Ross, L., “All donations should not be treated equally: a response to Jeffrey Kahn’s commentary’, Journal of Law, Medicine and Ethics, 30 (2002), 448–51.
364. Rothman, S. and Rothman, D., “The hidden cost of organ sale’, American Journal of Transplantation, 6 (2006), 1524–8.
365. Royal College of Surgeons of England, The Report of the Working Party to Review Organ Transplantation (Royal College of Surgeons, 1999).
366. Ruiz Jiménez, J. and Tejedor Muñoz, L., “Notas sobre la responsabilidad en torno a las donaciones de órganos cuando el donante es un menor’, Revista Crítica Derecho Inmobiliario, 705 (2008), 427–40.
367. Sanner, M., “A comparison of public attitudes toward autopsy, organ donation and anatomic dissection’, Journal of the American Medical Association, 271 (1994), 284–8.
368. Sanner, M., “People’s attitudes and reactions to organ donation’, Mortality, 11 (2006), 133–50.
369. Sarnesto, S., Uusin tutkimus: suomalaisilla on myönteinen asenne elinluovutukseen (12 October 2006), www.musili.fi/fin/ajankohtaista/?nid=20&fs=m.
370. Sasso-Mendes, K., Curvo, P., Silveira, R., Galvao, C., “Organ donation: acceptance and refusal among users of the public health system from Brasil’, Transplantation Proceedings, 40 (2008), 660–2.
371. Satz, D., “Why should some things not be for sale?’ in Cullenberg, S. and Pattanaik, P. (eds.), Globalization, Culture, and the Limits of the Market (Oxford University Press, 2004), pp. 10–37.
372. Scandiatransplant, Waiting List and Transplantation Figures According to European Standard (2007), www.scandiatransplant.org/tx_newsletter2007.htm.
373. Scandiatransplant, Diashow for Scandiatransplant (2008), www.scandiatransplant.org/aar08_04/dias2008.html.
374. Scandiatransplant, Transplantation and Waiting List Figures Quarterly (2006–2009), www.scandiatransplant.org.
375. Schauenburg, H. and Hildebrandt, A., “Public knowledge and attitudes on organ donation do not differ in Germany and Spain’, Transplantation Proceedings, 38 (2006), 1218–20.
376. Scheper-Hughes, N., “The tyranny of the gift: sacrificial violence in living donor transplants’, American Journal of Transplantation, 7 (2007), 507–11.
377. Scheufele, D., “Messages and heuristics: how audiences form attitudes about emerging technologies’ in Turney, J. (ed.), Engaging Science: Thoughts, Deeds, Analysis and Action (London: Wellcome Trust, 2006), pp. 20–5.
378. Schicktanz, S. and Schweda, M., ““One man’s trash is another man’s treasure”: exploring economic and moral subtexts of the “organ shortage” problem in public views on organ donation’, Journal ofMedical Ethics, 35 (2009), 473–6.
379. Schol, J., Srinivas, T., Sehgal, A., Meier-Kriesche, H., “Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant’, Clinical Journal of the American Society of Nephrology, 4 (2009), 1239–45.
380. Schweda, M. and Schicktanz, S., “Public moralities concerning donation and disposition of organs: results from a cross-European study’, Cambridge Quarterly of Healthcare Ethics, 17 (2008), 308–17.
381. Schweda, M. and Schicktanz, S., “Public ideas and values concerning the commercialization of organ donation in four European countries’, Social Science & Medicine, 68 (2009), 1129–36.
382. Scottish Transplant Group, An Organ Donation Strategy for Scotland: Scottish Transplant Group Report (June 2002), (www.sedh.scot.nhs.uk/publications/odss/odss.pdf).
383. Seale, C., “Heroic death’, Sociology, 29 (1995), 597–613.
384. Seale, C., Constructing Death: the Sociology of Dying and Bereavement (Cambridge University Press, 1998).
385. Sells, R., “Voluntarism and coercion in living organ donation’ in Collins, G., Dubernard, J., Land, W., Persijn, G. (eds.), Procurement, Preservation and Allocation of Vascularized Organs (Dordrecht: Kluwer Academic Publishers, 1997), pp. 295–300.
386. Sells, R., “What is transplantation law and whom does it serve?’, Transplantation Proceedings, 35 (2003), 1191–4.
387. Shafer, T., Wagner, D., Chessare, J., Zampiello, F., McBride, V., Perdue, J., “Increasing organ donation through system redesign’, Critical Care Nursing Quarterly, 26 (2006), 33–48.
388. Shafer, T., Wagner, D., Chessare, J., Zampiello, F., McBride, V., Perdue, J., “Organ Donation Breakthrough Collaborative: increasing organ donation through system redesign’, Critical Care Nurse, 26 (2006), 23–49.
389. Shafer, T., Wagner, D., Chessare, J., Schall, M., McBride, V., Zampiello, F., Perdue, J., O’Connor, K., Lin, M., Burdick, J., “US Organ Donation Breakthrough Collaborative increases organ donation’, Critical Care Nursing Quarterly, 31 (2008), 190–210.
390. Sharpe, L., Strange Harvest: Organ Transplants, Denatured Bodies, and the Transformed Self (Berkeley: University of California Press, 2006).
391. Shemie, S., Baker, A., Knoll, G., Wall, W., Rocker, G., Howes, D., Davidson, J., Pagliarello, J., Chambers-Evans, J., Cockfield, S., Farrell, C., Glannon, W., Gourlay, W., Grant, D., Langevin, S., Wheelock, B., Young, K., Dossetor, J., “Donation after cardiocirculatory death in Canada’, Canadian Medical Association Journal, 175 (2006), S1–24.
392. Shewmon, D., “The brain and somatic integration: insights into the standard biological rationale for equating “brain death” with death’, Journal of Medicine and Philosophy, 26 (2001), 457–78.
393. Shipman Inquiry, The (2005), www.the-shipman-inquiry.org.uk.
394. Siminoff, L. and Chillag, K., “The fallacy of the “Gift of Life”’, The Hastings Center Report, 29 (1999), 34–41.
395. Smith, M. and Murphy, P., “The Ministerial Taskforce on Organ Donation’, Journal of the Intensive Care Society, 9 (2008), 72–6.
396. Snoeijs, M., van Heurn, L., van Mook, W., Christiaans, M., van Hooff, J., “Controlled donation after cardiac death: a European perspective’, Transplantation Reviews, 21 (2007), 219–29.
397. Soukup, M., “Organ donation from the family of a totally brain-dead donor: professional responsiveness’, Critical Care Nursing, 13 (1991), 8–18.
398. Sque, M., “A Story to Tell’: Post Bereavement Correspondence between Organ Donor Families, Recipients, their OPOs and the National Donor Family Council – An American Investigation (a report of a study funded by The General Nursing Council of England and Wales Trust) (University of Surrey, 2000).
399. Sque, M., Long, T. and Payne, S., Organ and Tissue Donation: Exploring the Needs of Families (final report of a three-year study commissioned by the British Organ Donor Society, funded by the Community Fund) (University of Southampton, 2003).
400. Sque, M., Long, T. and Payne, S., From Understanding to Implementation: Meeting the Needs of Families and Individuals Affected by Post-Mortem Organ Retention (final report of a study funded by the Department of Health and The Retained Organs Commission) (University of Southampton, 2004).
401. Sque, M., Long, T., Payne, S., Allardyce, D., Exploring the end of life decisionmaking and hospital experiences of families who did not donate organs for transplant operations. Final Report for UK Transplant (University of Southampton, 2006).
402. Sque, M., Long, T., Payne, S., Allardyce, D., “Why relatives do not donate organs for transplants: “sacrifice” or “gift of life”?’, Journal of Advanced Nursing, 61 (2008), 134–44.
403. Sque, M., Long, T., Payne, S., Roche, W., Speck, P., “TheUKpost mortem organ retention crisis: a qualitative study of its impact on parents’, Journal of the Royal Society of Medicine, 101 (2008), 71–7.
404. Sque, M. and Payne, S., “Gift exchange theory: a critique in relation to organ transplantation’, Journal of Advanced Nursing, 19 (1994), 45–51.
405. Sque, M. and Payne, S., “Dissonant loss: the experience of donor relatives’, Social Science&Medicine, 43 (1996), 1359–70.
406. Sque, M., Payne, S. and Macleod Clark, J., “Gift of life or sacrifice? Key discourses to understanding organ donor families’ decision-making’, Mortality, 11 (2006), 117–32.
407. Sque, M., Payne, S. and Macleod Clark, J., “Gift of life or sacrifice? Key discourses for understanding decision-making by families of organ donors’ in Sque, M. and Payne, S. (eds.), Organ and Tissue Donation: an Evidence Base for Practice (Maidenhead: Open University Press, 2007), pp. 40–58.
408. Sque, M., Payne, S. and Vlachonikolis, I., “Cadaveric donor transplantation: nurses’ attitudes, knowledge and behaviour’, Social Science & Medicine, 50 (2000), 541–52.
409. Starzl, T., Marchioro, T., Holmes, J., Hermann, G., Brittain, R., Stonington, O., Talmage, D., Waddell, W., “Renal homografts in patients with major donorrecipient blood group incompatibilities’, Surgery, 55 (1964), 195–200.
410. Stein, R., “States revising organ-donation law: critics fear measure may not go far enough to protect donors’, Washington Post, 4 April 2007, A01.
411. Steinbrook, R., “Organ donation after cardiac death’, Journal of the American Medical Association, 357 (2007), 209–13.
412. Stewart, J., “First Canadian live-donor lung transplants performed in Winnipeg’, Canadian Medical Association Journal, 162 (2000), 1339.
413. Stroebe, M. and Schut, H., “The dual process model of coping with bereavement: rationale and description’, Death Studies, 23 (1999), 197–224.
414. Stroebe, M. and Schut, H., “To continue or relinquish bonds: a review of consequences for the bereaved’, Death Studies, 29 (2005), 477–94.
415. Tanabe, K., Takahashi, K., Sonda, K., Tokumoto, T., Ishikawa, N., Kawai, T., Fuchinoue, S., Oshima, T., Yagisawa, T., Nakazawa, H., Goya, N., Koga, S., Kawaguchi, H., Ito, K., Toma, H., Agishi, T., Ota, K., “Long-term results of ABO-incompatible living kidney transplantation: a single-center experience’, Transplantation, 65 (1998), 224–8.
416. Tanabe, K., Tokumoto, T., Ishida, H., Ishikawa, N., Miyamoto, N., Kondo, T., Shimmura, H., Setogucji, K., Toma, H., “Excellent outcome of ABOincompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid’, Transplantation Proceedings, 36 (2004), 2175–7.
417. Tavakol, M., Vincenti, F., Assadi, H., Frederick, M., Tomlanovich, S., Roberts, J., Posselt, A., “Long-term renal function and cardiovascular disease in obese kidney donors’, Clinical Journal of the American Society of Nephrology, 4 (2009), 1230–8.
418. Taylor, J., Stakes and Kidneys: why Markets in Human Body Parts are Morally Imperative (Burlington: Ashgate Press, 2005).
419. Terés, J., “Transplantament hepàtic de donant viu a l’adult. Elements per una anàlisi ètica’, Annals de Medicina, 87 (2004), 1–10.
420. Textor, S., Taler, S., Driscoll, N., Larson, T., Gloor, J., Griffin, M., Cosio, F., Schwab, T., Prieto, M., Nyberg, S., Ishitani, M., Stegall, M., “Blood pressure and renal function after kidney donation from hypertensive living donors’, Transplantation, 78 (2004), 276–82.
421. Textor, S., Taler, S., Larson, T., Prieto, M., Griffin, M., Gloor, J., Nyberg, S., Velosa, J., Schwab, T., Stegall, M., “Blood pressure evaluation among older living kidney donors’, Journal of the American Society of Nephrology, 14 (2003), 2159–67.
422. The Concise Oxford Dictionary, 10th edn (Oxford University Press, 2001).
423. The Gallup Organization, 2005 National Survey of Organ and Tissue Donation Attitudes and Behavior, www.organdonor.gov.
424. The Retained Organs Commission, External Review of Birmingham Children’s Hospital NHS Trust: Report on Organ Retention (London: Department of Health, 2002).
425. The Retained Organs Commission, Investigation into Organ Retention at Central Manchester and Manchester Children’s University Hospitals (London: Department of Health, 2002).
426. Titmuss, R., The Gift Relationship: from Human Blood to Social Policy (London: Allen & Unwin, 1970).
427. Tomlinson, T., “The irreversibility of death: reply to Cole’, Kennedy Institute of Ethics Journal, 3 (1993), 157–65.
428. Tonelli, M., Klarenbach, S., Manns, B., Culleton, B., Hemmelgarn, B., Bertazzon, S., Wiebe, N., Gill, J., for the Alberta Kidney Disease Network, “Residence location and likelihood of kidney transplantation’, Canadian Medical Assocation Journal, 175 (2006), 478–82.
429. Tong, A., Howard, K., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J., “Community preferences for allocation of solid organs for transplantation: a systematic review’, Transplantation, 89 (2010), 796–805.
430. Truog, R., “The ethics of organ donation by living donors’, New England Journal of Medicine, 353 (2005), 444–6.
431. Truog, R. and Miller, F., “The dead donor rule and organ transplantation’, New England Journal of Medicine, 359 (2008), 674–5.
432. Tuomilehto, J., Lindstrom, J., Eriksson, J., Valle, T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Aunola, S., Cepaitis, Z., Moltchanov, V., Hakumaki, M., Mannelin, M., Martikkala, V., Sundvall, J., Uusitupa, M. and Group, for the Finnish Diabetes Prevention Study Group, “Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance’, New England Journal of Medicine, 344 (2001), 1343–50.
433. Ubel, P., “How stable are people’s preferences for giving priority to severely ill patients?’, Social Science & Medicine, 49 (1999), 895–903.
434. Ubel, P. and Loewenstein, G., “Distributing scarce livers: the moral reasoning of the general public’, Social Science & Medicine, 42 (1996), 1049–55.
435. UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)’, Lancet, 352 (1998), 837–53.
436. UK Registry of Antibody Incompatible Renal Transplantation (2001–2009).
437. UK Transplant, Guidelines 3.2, Donor Organ Sharing Scheme: Operating Principles for Cardiothoracic Transplant Units in the UK and the Republic of Ireland, www.organdonation.nhs.uk.
438. UK Transplant, Potential Donor Audit: Summary Report for the 24 month period 1 April 2006 – 31 March 2008 (2008).
439. UK Transplant, Potential Donor Audit: 36-Month Summary Report 1 April 2003 – 31 March 2006 (2008).
440. United Network for Organ Sharing (UNOS), Policy 6.0, Transplantation of Non-Resident Aliens (2005).
441. United Network for Organ Sharing (UNOS), Position Statement: Intended Recipient Donations, Paired Donations and NOTA 301 (2005), www.unos.org/publications.
442. United Network for Organ Sharing (UNOS), Resource Document for Informed Consent of Living Donors (18 September 2007), www.unos.org.
443. United States Attorney General’s Office, Memorandum for General Counsel, Department of Health and Human Services: Legality of Alternative Organ Donation Practices Under 42 USC § 274e (28 March 2007).
444. United States Renal Data System, “2006 Annual Data Report’, American Journal of Kidney Disease, 114 (2007), 2806–2814.
445. van Dijk, G., Hilhorst, M., Financial Incentives for Organ Donation: an Investigation of the Ethical Issues (Ethics and Health Monitoring Report 2007/3) (The Hague: Centre for Ethics and Health, 2007) (www.ceg.nl/data/download/Orgaandonatie_huisstijl_eng_def.pdf).
446. Vancouver Forum, “The Ethics Statement of the Vancouver Forum on the live long, liver, pancreas, and intestine donor’, Transplantation, 81 (2006), 1386–7.
447. Veatch, R., Death, Dying and the Biological Revolution – Our Last Quest for Responsibility (Yale University Press, 1976).
448. Veatch, R., Transplantation Ethics (Washington, DC: Georgetown University Press, 2000).
449. Veatch, R., “Why liberals should accept financial incentives for organ procurement’, Kennedy Institute of Ethics Journal, 13 (2003), 19–36.
450. Veatch, R., “Donating hearts after cardiac death – reversing the irreversible’, New England Journal of Medicine, 359 (2008), 672–3.
451. Volk, M., Lok, A., Pelletier, S., Ubel, P., Hayward, R., “Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation’, Gastroenterology, 135 (2008), 1568–74.
452. Waite, S. and Nolte, E., “Public involvement policies in health: exploring their conceptual basis’, Health Economics, Policy and Law, 1 (2006), 149–62.
453. Walter, T., The Revival of Death (London: Routledge, 1994).
454. Walter, T., “A new model of grief: bereavement and biography’, Mortality, 1 (1996), 1–29.
455. Waterman, A., Schenk, E., Barrett, A., Waterman, B., Rodrigue, J., Woodle, E., Shenoy, S., Jendrisak, M., Schnitzler, M., “Incompatible kidney donor candidates’ willingness to participate in donor-exchange and non-directed donation’, American Journal of Transplantation, 6 (2006), 1631–8.
456. Wellcome Trust, Public Perspectives on Human Cloning (London: Wellcome Trust, 1998).
457. Wertheimer, A., Coercion (Princeton University Press, 1987).
458. Wertheimer, A., Exploitation (Princeton University Press, 1999).
459. West, S., Pollock-Barziv, A., Dipchand A., Lee, K., Cardella, C., Benson, L., Rebeyka, I., Coles, J., “ABO incompatible heart transplantation in infants’, New England Journal of Medicine, 344 (2001), 793–800.
460. Westen, P., The Logic of Consent (Aldershot: Ashgate, 2004).
461. Wilkinson, S., Bodies for Sale: Ethics and Exploitation in the Human Body Trade (London: Routledge, 2003).
462. Wilkinson, T., “Living donor organ transplantation’ in Ashcroft, R., Dawson, A., Draper, H. and McMillan, J. (eds.), Principles of Health Care Ethics, 2nd edn (Chichester: John Wiley, 2007), pp. 482–8.
463. Williams, C., Alderson, P. and Farsides, B., “Dilemmas encountered by health care practitioners offering nuchal translucency screening: a qualitative case study’, Prenatal Diagnosis, 22 (2002), 216–20.
464. Wilsden, J. and Willis, R., See-Through Science: Why Public Engagement Needs to Move Upstream (London: Demos, 2004).
465. Worden, J., Grief Counselling and Grief Therapy: a Handbook for the Mental Health Practitioner, 3rd edn (New York: Springer Publishing, 2002).
466. Worthington, J., McEwen, A., McWilliam, L., Picton, M., Martin, S., “Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome’, Transplantation, 83 (2007), 398–403.
467. Wright, B., Sudden Death: a Research Base for Practice, 2nd edn (New York: Churchill Livingstone, 1996).
468. Wright, L., Faith, K., Richardson, R., Grant, D., “Ethical guidelines for the evaluation of living organ donors’, Canadian Journal of Surgery, 47 (2004), 408–14.
469. Yates, D., Ellison, G. and McGuiness, S., “Care of the suddenly bereaved’, British Medical Journal, 301 (1990), 29–31.
470. Young, A., Storsley, L., Garg, A., Treleaven, D., Nquan, C., Cuerden, M., Karpinski, M., “Health outcomes for living kidney donorswith isolatedmedical abnormalities: a systematic review’, American Journal of Transplantation, 8 (2008), 1878–90.
471. Youngner, S., Arnold, R. and De Vita, M., “When is “dead”?’, Hastings Center Report, 29 (1999), 14–21.
472. Youngner, S., Arnold, R. and Shapiro, R. (eds.), The Definition of Death: Contemporary Controversies (Baltimore: Johns Hopkins University Press, 1999).
473. Zaltzman, Z., “Kidney transplantation in Canada: unequal access’, Canadian Medical Association Journal, 175 (2006), 489–90.
474. BC Transplant – www.transplant.bc.ca
475. Canadian Council for Donation and Transplantation – www.ccdt.ca/collaborative/index.html
476. Quebec Transplant – www.quebec-transplant.qc.ca
477. Trillium Gift of Life – www.giftoflife.on.ca
478. Nordic countries Scandiatransplant – www.scandiatransplant.org
479. United Kingdom Give and Let Live – www.giveandletlive.co.uk
480. How to Become a Donor – www.uktransplant.org.uk
481. National Institute for Health and Clinical Excellence (NICE) – www.nice.org.uk
482. NHS Blood and Transplant – www.nhsbt.nhs.uk
483. NHS Blood and Transplant (NHSBT), Organ Donation and Transplantation Directorate – www.organdonation.nhs.uk
484. Organ and Tissue Donation: Your Questions Answered – www.uktransplant.org.uk
485. Personal Social Health and Economic Education Association – www.psheassociation.org.uk
486. Your health, your choices – www.nhs.uk
487. United States Uniform Law Commission – www.nccusl.org
488. United Network of Organ Sharing (UNOS) – www.unos.org